Lee Scott Taylor •

Lee Scott Taylor is a seasoned professional in the healthcare sector, currently serving as Head of Europe for Continuous Glucose Monitoring at Sinocare Meditech Inc. since December 2022, leading marketing and access initiatives for the iCan CGM system, which is the first Chinese device to receive a CE mark under European MDR. As the Founder and Managing Director of licensing life sciences since 2018, Lee Scott Taylor specializes in forging partnerships for medical device and pharmaceutical companies. With a robust background that includes leadership roles at MENARINI Group, Cambridge Cognition Plc, Daiichi Sankyo UK Ltd, Novartis UK, and GSK, Lee Scott Taylor has a proven track record in sales growth and market access. Currently, Lee Scott Taylor holds membership positions with several reputable organizations, including the European Association for the Study of Diabetes, the International Diabetes Federation, and Diabetes UK. Education includes credentials from ABPI and the Royal Army Medical School.